Premature Ovarian Insufficiency

被引：0

作者：

Böttcher B. ^{[1
]}

机构：

[1] Klinik für Gyn. Endokrinologie und Reproduktionsmedizin, Medizinische Universität Innsbruck, Anichstr. 35, Innsbruck

来源：

Journal für Gynäkologische Endokrinologie/Österreich | 2023年 / 33卷 / 3期

关键词：

Bone mass; Cognitive deficits; Early menopause; Fertility preservation; Infertility;

D O I：

10.1007/s41974-023-00276-9

中图分类号：

学科分类号：

摘要：

Premature ovarian insufficiency (POI) is characterized by amenorrhea and elevated follicle stimulating hormone (FSH) levels. It may occur spontaneously, be caused by chronic or autoimmune diseases, or be genetic or iatrogenic due to gonadotoxic or surgical therapy. Diagnostics include determination of the respective laboratory parameters, sonography, bone density scan and genetics depending on the medical history. Early initiation of hormone replacement therapy is indicated to reduce cardiovascular risks, improve urogenital and vasomotor symptoms as well as bone density and should be continued until natural menopausal age is reached at approximately 50 years. © 2023, The Author(s).

引用

页码：100 / 105

页数：5

共 22 条

[1]

Coulam C.B., Adamson S.C., Annegers J.F., Incidence of premature ovarian failure, Obstet Gynecol, 67, 4, pp. 604-606, (1986)

[2]

Vegetti W., Tibiletti G.M., Testa G., de Lauretis Y., Alagna F., Castoldi E., Et al., Inheritance in idiopathic premature ovarian failure: analysis of 71 cases, Hum Reprod, 13, 7, pp. 1796-1800, (1998)

[3]

Management of women with premature ovarian insufficiency, Guideline of the European Society of Human Reproduction and Embryology, (2015)

[4]

Bachelot A., Rouxel A., Massin N., Dulon J., Courtillot C., Matuchansky C., Et al., Phenotyping and genetic studies of 357 consecutive patients presenting with premature ovarian failure, Eur J Endocrinol, 161, 1, pp. 179-187, (2009)

[5]

Goldenberg R.L., Grodin J.M., Rodbard D., Ross G.T., Gonadotropins in women with amenorrhea. The use of plasma follicle-stimulating hormone to differentiate women with and without ovarian follicles, Am J Obstet Gynecol, 116, 7, pp. 1003-1012, (1973)

[6]

Guidelines. Menopause: diagnosis and management, (2019)

[7]

Weidlinger S.S.P., Die prämature Ovarialinsuffizienz, Gynäkologie, 3, pp. 24-28, (2018)

[8]

Maclaran K., Panay N., Premature ovarian failure, J Fam Plann Reprod Health Care, 37, 1, pp. 35-42, (2011)

[9]

Jiao X., Qin C., Li J., Qin Y., Gao X., Zhang B., Et al., Cytogenetic analysis of 531 Chinese women with premature ovarian failure, Hum Reprod, 27, 7, pp. 2201-2207, (2012)

[10]

Wittenberger M.D., Hagerman R.J., Sherman S.L., McConkie-Rosell A., Welt C.K., Rebar R.W., Et al., The FMR1 premutation and reproduction, Fertil Steril, 87, 3, pp. 456-465, (2007)

← 1 2 3 →